Cortland Associates’s AbbVie ABBV Stock Holding History

Cortland Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,077	Closed	-$223K	–	61
2020 Q4	$223K	Buy	+2,077	New	+$200K	0.03%	55
2020 Q3	–	Sell	-2,076	Closed	-$204K	–	58
2020 Q2	$204K	Buy	+2,076	New	+$183K	0.03%	49
2020 Q1	–	Sell	-2,674	Closed	-$237K	–	48
2019 Q4	$237K	Buy	+2,674	New	+$222K	0.03%	47
2019 Q1	–	Sell	-2,364	Closed	-$218K	–	55
2018 Q4	$218K	Buy	2,364 +30	+1%	+$2.64K	0.04%	45
2018 Q3	$221K	Hold	2,334	–	–	0.03%	50
2018 Q2	$216K	Sell	2,334 -205	-8%	-$20K	0.04%	49
2018 Q1	$240K	Buy	+2,539	New	+$279K	0.04%	50

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cortland Associates's ABBV Position: Q1 2021 in Review

Cortland Associates sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 2,077 shares — an estimated $223K sold.

Cortland Associates first reported a position in ABBV in Q1 2018 and held it in 7 quarters. The position peaked at $240K in Q1 2018. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

Cortland Associates reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
Cortland Associates sold 2,077 AbbVie shares in Q1 2021, an estimated $223K.
Cortland Associates first reported a position in AbbVie in Q1 2018 and held it in 7 quarters.
Cortland Associates's AbbVie position peaked at $240K in Q1 2018.
2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Cortland Associates's 13F filing for Q1 2021, filed 4 May 2021.